Thomas L. LaPorte

557 total citations
17 papers, 349 citations indexed

About

Thomas L. LaPorte is a scholar working on Molecular Biology, Organic Chemistry and Biomedical Engineering. According to data from OpenAlex, Thomas L. LaPorte has authored 17 papers receiving a total of 349 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Organic Chemistry and 5 papers in Biomedical Engineering. Recurrent topics in Thomas L. LaPorte's work include Innovative Microfluidic and Catalytic Techniques Innovation (4 papers), Viral Infectious Diseases and Gene Expression in Insects (4 papers) and Analytical Chemistry and Chromatography (2 papers). Thomas L. LaPorte is often cited by papers focused on Innovative Microfluidic and Catalytic Techniques Innovation (4 papers), Viral Infectious Diseases and Gene Expression in Insects (4 papers) and Analytical Chemistry and Chromatography (2 papers). Thomas L. LaPorte collaborates with scholars based in United States, Netherlands and Switzerland. Thomas L. LaPorte's co-authors include Ronald L. Hanson, Ramesh N. Patel, Michael J. Lawler, Elizabeth Fisher, Stefan G. Koenig, Anne O’Kearney-McMullan, Martin D. Johnson, Julie B. Manley, Peter Poechlauer and Juan Colberg and has published in prestigious journals such as The Journal of Organic Chemistry, Biotechnology and Bioengineering and Enzyme and Microbial Technology.

In The Last Decade

Thomas L. LaPorte

17 papers receiving 326 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas L. LaPorte United States 10 189 116 93 56 46 17 349
Ekaterina Varlamova United States 9 44 0.2× 135 1.2× 112 1.2× 116 2.1× 12 0.3× 17 439
Anne O’Kearney-McMullan United Kingdom 12 244 1.3× 82 0.7× 186 2.0× 62 1.1× 41 0.9× 18 398
Brian J. Neely United States 14 167 0.9× 45 0.4× 121 1.3× 69 1.2× 69 1.5× 24 420
Jean‐Paul Roduit Switzerland 9 116 0.6× 168 1.4× 208 2.2× 22 0.4× 9 0.2× 13 374
Naresh Pavurala United States 12 94 0.5× 59 0.5× 34 0.4× 138 2.5× 27 0.6× 21 464
Lucius T. Rossano United States 11 36 0.2× 137 1.2× 253 2.7× 36 0.6× 25 0.5× 13 382
Shane T. Grosser United States 12 153 0.8× 132 1.1× 31 0.3× 51 0.9× 18 0.4× 22 283
Rohini R. Joshi India 9 100 0.5× 73 0.6× 182 2.0× 27 0.5× 15 0.3× 21 271
Mark T. Maloney United States 11 230 1.2× 139 1.2× 202 2.2× 47 0.8× 11 0.2× 19 532
W. Bäcker Germany 8 93 0.5× 112 1.0× 17 0.2× 138 2.5× 29 0.6× 16 389

Countries citing papers authored by Thomas L. LaPorte

Since Specialization
Citations

This map shows the geographic impact of Thomas L. LaPorte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas L. LaPorte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas L. LaPorte more than expected).

Fields of papers citing papers by Thomas L. LaPorte

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas L. LaPorte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas L. LaPorte. The network helps show where Thomas L. LaPorte may publish in the future.

Co-authorship network of co-authors of Thomas L. LaPorte

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas L. LaPorte. A scholar is included among the top collaborators of Thomas L. LaPorte based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas L. LaPorte. Thomas L. LaPorte is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Singh, Àmarjit, et al.. (2015). Enzymatic Process for N-Substituted (3S)- and (3R)-3-Hydroxypyrrolidin-2-ones. Organic Process Research & Development. 19(7). 819–830. 5 indexed citations
2.
Ramı́rez, Antonio, Michael J. Lawler, Yun K. Ye, et al.. (2014). The Effect of Additives on the Zinc Carbenoid-Mediated Cyclopropanation of a Dihydropyrrole. The Journal of Organic Chemistry. 79(13). 6233–6243. 8 indexed citations
3.
LaPorte, Thomas L., et al.. (2014). Development of a Continuous Plug Flow Process for Preparation of a Key Intermediate for Brivanib Alaninate. Organic Process Research & Development. 18(11). 1492–1502. 16 indexed citations
4.
Lobben, Paul C., Alan Braem, Shih‐Ying Chang, et al.. (2014). Control Strategy for the Manufacture of Brivanib Alaninate, a Novel Pyrrolotriazine VEGFR/FGFR Inhibitor. Organic Process Research & Development. 19(8). 900–907. 6 indexed citations
5.
Pesti, Jaan A., et al.. (2013). Commercial Synthesis of a Pyrrolotriazine–Fluoroindole Intermediate to Brivanib Alaninate: Process Development Directed toward Impurity Control. Organic Process Research & Development. 18(1). 89–102. 15 indexed citations
6.
Poechlauer, Peter, Juan Colberg, Elizabeth Fisher, et al.. (2013). Pharmaceutical Roundtable Study Demonstrates the Value of Continuous Manufacturing in the Design of Greener Processes. Organic Process Research & Development. 17(12). 1472–1478. 124 indexed citations
7.
LaPorte, Thomas L., et al.. (2008). Development and Scale-Up of Three Consecutive Continuous Reactions for Production of 6-Hydroxybuspirone. Organic Process Research & Development. 12(5). 956–966. 36 indexed citations
8.
LaPorte, Thomas L., et al.. (2007). Continuous processes for the production of pharmaceutical intermediates and active pharmaceutical ingredients.. PubMed. 10(6). 738–45. 24 indexed citations
9.
Springer, Dane M., Margaret E. Sorenson, Stella Huang, et al.. (2003). Synthesis and activity of a C-8 keto pleuromutilin derivative. Bioorganic & Medicinal Chemistry Letters. 13(10). 1751–1753. 29 indexed citations
10.
Hanson, Ronald L., James A. Matson, David B. Brzozowski, et al.. (2002). Hydroxylation of Mutilin by Streptomyces griseus and Cunninghamella echinulata. Organic Process Research & Development. 6(4). 482–487. 26 indexed citations
11.
Nanduri, Venkata, Ronald L. Hanson, Animesh Goswami, et al.. (2001). Biochemical approaches to the synthesis of ethyl 5-(s)-hydroxyhexanoate and 5-(s)-hydroxyhexanenitrile. Enzyme and Microbial Technology. 28(7-8). 632–636. 16 indexed citations
13.
LaPorte, Thomas L., et al.. (1996). Long term shear effects on a hybridoma cell line by dynamic perfusion devices. Bioprocess and Biosystems Engineering. 15(1). 1–7. 2 indexed citations
14.
Nanduri, Venkata, et al.. (1995). Fermentation and isolation of C10‐deacetylase for the production of 10‐deacetylbaccatin III from baccatin III. Biotechnology and Bioengineering. 48(5). 547–550. 12 indexed citations
15.
LaPorte, Thomas L., Jerry Shevitz, Youngsun Kim, & Shaw S. Wang. (1995). Hybridoma perfusion system using a sedimentation device. Biotechnology Techniques. 9(11). 837–842. 1 indexed citations
16.
Chen, Yi‐Kai, Thomas L. LaPorte, Shaw S. Wang, & Jerry Shevitz. (1992). High density culture of HeLa cells in a CelliGen perfusion system. Cytotechnology. 8(1). 85–88. 2 indexed citations
17.
Shevitz, Jerry, et al.. (1990). Production of viral vaccines in stirred bioreactors.. PubMed. 14. 1–35. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026